Patent details

Basic Information

Publication number:

92678

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP019351261

Legal Status:

Active

Application number:

92678

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/10/652/001-003 - TOBI Podhaler-Tobramycine

Marketing Authorization Type:

Marketing Authorization Date:

25/07/2011

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

11/03/2015

First Marketing Authorization date:

25/07/2011

Grant date:

02/11/2015

Activation date:

08/05/2021

Publication date:

02/11/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

08/05/2026

SPC Extension Expiration:

08/05/2026

Rejection date:

Withdrawal date:

Owner

From:

11/03/2015

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4002 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/03/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

DELLAMARY Luis, A.

Address:

United States (US)

2

Name:

RIESS Jean, G.

Address:

France (FR)

3

Name:

SCHUTT Ernest, G.

Address:

United States (US)

4

Name:

TARARA Thomas, E.

Address:

United States (US)

5

Name:

WEERS Jeffry, G.

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2021/07

Publication date:

03/06/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

29/04/2025

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages